LiVeritas Biosciences — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

LiVeritas Biosciences is a private, early-stage company founded in 2021 that operates at the intersection of AI, laboratory services, and regulatory science. The company has built a full-stack, AI-powered platform (LiLii™) to intelligently execute and manage regulated testing workflows for drug developers, with a focus on mass spectrometry characterization for biologics, ADCs, and cell/gene therapies. By positioning itself as a 'Trusted Execution Layer,' LiVeritas aims to decrease testing cycle times, ensure compliance, and accelerate IND filings for its biopharma clients. The company appears to be in an early-revenue phase, leveraging a hybrid business model combining its proprietary software platform with contract research organization (CRO)-like analytical services.

Hepatology

Technology Platform

LiLii™ - A compliance-native, full-stack agentic AI operating system designed to automate and manage regulated drug testing workflows. It integrates project management, CRM, document control, and analytics, using intelligent agents to execute laboratory processes audit-ready by design.

Funding History

1

SeedUndisclosedUndisclosedJun 15, 2022

Opportunities

The rapid growth of complex biologics, ADCs, and cell/gene therapies creates strong demand for sophisticated, rapid analytical testing.

Concurrently, the industry-wide push for AI-driven efficiency presents a major opportunity to establish a new standard for compliant, automated testing workflows, potentially capturing significant market share from traditional CROs.

Risk Factors

Key risks include the technical challenge of developing robust, validated agentic AI for variable lab processes; convincing a conservative industry to adopt a novel AI-driven platform for critical regulatory work; and the significant financial burn rate required to fund both a wet-lab service operation and a sophisticated software platform simultaneously.

Competitive Landscape

LiVeritas competes with established analytical CROs (e.g., part of large players like LabCorp, Charles River, Eurofins) that offer mass spec services and are developing digital tools, as well as with emerging AI/software startups focused on lab automation and data analysis. Its differentiation is the deep integration of compliance-native AI agents directly into execution workflows, rather than offering point solutions or services alone.

More companies in AI / Machine Learning →More companies in United States →